Skip to main content
BIOME AUSTRALIA LIMITED logo

BIOME AUSTRALIA LIMITED — Investor Relations & Filings

Ticker · BIO ISIN · AU0000184137 ASX Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2024-06-20 Share Issue/Capital Cha…
Country AU Australia
Listing ASX BIO

About BIOME AUSTRALIA LIMITED

https://www.biomeaustralia.com

Biome Australia Limited is a microbiome health company specializing in the development and distribution of evidence-based probiotics and complementary medicines. The company focuses on translating microbiome science into accessible healthcare solutions through its flagship brand, Activated Probiotics. Its product portfolio consists of condition-specific formulations designed to address various health areas, including digestive health, immune system support, bone density, and mental wellbeing via psychobiotics. Biome Australia prioritizes clinical research and collaborates with global experts to ensure the efficacy of its formulations. The company’s distribution strategy centers on a network of community pharmacies and independent health practitioners, providing professional-grade supplements to the retail and clinical markets.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - BIO 6 pages 18.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from Biome Australia Limited regarding the application for quotation of securities on the ASX. It details the securities issued as a result of options being exercised or convertible securities being converted, including the number of securities, issue dates, and other related information. This type of document is a formal application to list or quote securities on the stock exchange, which corresponds to announcements about share issues or capital changes. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (5730 characters) and content confirm it is a full announcement, not just a brief notice or report publication announcement.
2024-06-20 English
Secondary Trading Notice 2 pages 293.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 21 June 2024 regarding the issuance of shares following the exercise of options by Biome Australia Limited. It references compliance with the Corporations Act 2001, specifically section 708A(5), which relates to exemptions for the on-sale of securities issued without disclosure. The announcement details the number of shares issued, the amount received, and confirms compliance with disclosure requirements. It does not contain financial statements or detailed financial analysis, nor does it present a full report. The document is relatively short (3684 characters) and serves as a formal notice of a capital raising event via option exercise, which is a financing activity. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-06-20 English
Application for quotation of securities - BIO 7 pages 20.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) form used for the application for quotation of securities. It details the issuance and quotation of securities under an employee incentive scheme, including the number of securities, issue date, and other listing rule requirements. There are no financial statements, earnings data, or management discussion present. The document is an official announcement related to capital changes, specifically the quotation of new shares issued under an employee incentive plan. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement but a formal application for quotation of securities.
2024-06-13 English
Secondary Trading Notice 2 pages 247.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 14 June 2024 regarding the issuance of 131,416 shares under the company's Employee Incentive Plan. It references compliance with section 708A(5) of the Corporations Act 2001, which relates to secondary trading notices and exemptions for on-sale of securities issued without disclosure. The document does not contain financial statements or detailed financial data, nor does it announce a report or provide a transcript. It is a regulatory announcement about share issuance and compliance with disclosure laws. The document length is 3051 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2024-06-13 English
Biome expects to exceed FY24 forecast 4 pages 248.9KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 12 June 2024 providing a trading update for Q4 FY24. It discusses expected revenue exceeding forecasts, positive cashflow and EBITDA for the quarter, and a product launch planned for Q1 FY25. The document does not contain detailed financial statements or comprehensive financial analysis but rather provides an update on trading performance and outlook. It is not a full quarterly or annual report, nor is it an earnings release with key highlights only. The document is longer than 5,000 characters and contains substantive information about financial performance and business updates for the quarter, which aligns with the characteristics of an Interim / Quarterly Report (IR). Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q4 2024
2024-06-11 English
International Market Update and Health Canada approvals 4 pages 264.0KB
Capital/Financing Update Classification · 85% confidence The document is an ASX announcement dated 29 May 2024, providing an update on Biome Australia Limited's international market expansion and Health Canada product approvals. It includes forward-looking statements, sales revenue expectations, regulatory approvals, and strategic plans for market launches. The content is a trading update and business progress report rather than a full financial report or earnings release. It does not contain detailed financial statements or comprehensive financial analysis. The document is not a report publication announcement since it contains substantive business update information. It is not a call transcript, management report, or capital update. The best fitting category is Capital/Financing Update (CAP) as it relates to business expansion, regulatory approvals, and market growth projections, which are typical of capital and financing updates in corporate announcements.
2024-05-28 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.